Atlas Trials

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Clinical trial NCT02806375 · COMPLETED

Trial details

NCT number
NCT02806375
Sponsor
St. Petersburg State Pavlov Medical University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Primary MyelofibrosisMyeloproliferative Disorders
Start date
2016-01-01
Primary completion
2018-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.